Cardiomyocyte apoptosis in the failing heart - A critical review from definition and classification of cell death

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 2373-2386

  Takemura, Genzou ^a   Kanoh, Motoo ^a   Minatoguchi, Shinya ^a   Fujiwara, Hisayoshi ^b  

^a GIFU UNIVERSITY   (Japan)

^b HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

Author keywords

Apoptosis; Cardiomyocytes; Cell death; Heart failure

Indexed keywords

ANIMAL CELL; APOPTOSIS; CELL DEATH; CELL STRUCTURE; CELL ULTRASTRUCTURE; CLASSIFICATION; DISEASE COURSE; DNA FRAGMENTATION; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; NONHUMAN; ORGANIZATION; PRIORITY JOURNAL; REVIEW; STANDARD;

APOPTOSIS; CARDIOMYOCYTES; CELL DEATH; HEART FAILURE;

ANIMALS; APOPTOSIS; CARDIOVASCULAR AGENTS; CELL DEATH; HEART FAILURE; HUMANS; MYOCYTES, CARDIAC;

EID: 84883793281     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.163     Document Type: Review

References (210)

1. R.A. Gottlieb, K.O. Burleson, R.A. Kloner, B.M. Babior, and R.L. Engler Reperfusion injury induces apoptosis in rabbit cardiomyocytes J Clin Invest 94 1994 1621 1628
2. G. Itoh, J. Tamura, and M. Suzuki DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis Am J Pathol 146 1995 1325 1331
3. J. Narula, N. Haider, and R. Virmani Apoptosis in myocytes in end-stage heart failure N Engl J Med 335 1996 1182 1189
4. G. Olivetti, R. Abbi, and F. Quaini Apoptosis in the failing human heart N Engl J Med 336 1997 1131 1141
5. J. Narula, F.D. Kolodgie, and R. Virmani Apoptosis and cardiomyopathy Curr Opin Cardiol 15 2000 183 188
6. C. Gill, R. Mestril, and A. Samali Losing heart: the role of apoptosis in heart disease - a novel therapeutic target? FASEB J 16 2002 135 146
7. A. Abbate, G.G. Biondi-Zoccai, and A. Baldi Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling J Cell Physiol 193 2002 145 153
8. A. González, M.A. Fortuño, and R. Querejeta Cardiomyocyte apoptosis in hypertensive cardiomyopathy Cardiovasc Res 59 2003 549 562
9. E. Arbustini, A. Brega, and J. Narula Ultrastructural definition of apoptosis in heart failure Heart Fail Rev 13 2008 121 135
10. L.M. Buja, and D. Vela Cardiomyocyte death and renewal in the normal and diseased heart Cardiovasc Pathol 17 2008 349 374
11. P.M. Kang, and S. Izumo Apoptosis and heart failure: a critical review of the literature Circ Res 86 2000 1107 1113
12. A. Elsässer, K. Suzuki, and J. Schaper Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure J Mol Cell Cardiol 32 2000 711 724
13. G. Takemura, and H. Fujiwara Morphological aspects of apoptosis in heart diseases J Cell Mol Med 10 2006 56 75
14. D. Sanchis, M. Llovera, M. Ballester, and J.X. Comella An alternative view of apoptosis in heart development and disease Cardiovasc Res 77 2008 448 451
15. D.J. Taatjes, B.E. Sobel, and R.C. Budd Morphological and cytochemical determination of cell death by apoptosis Histochem Cell Biol 129 2008 33 43
16. G. Kroemer, W.S. El-Deiry, and P. Golstein Nomenclature Committee on Cell Death. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death Cell Death Differ 12 Suppl. 2 2005 1463 1467
17. L. Galluzzi, M.C. Maiuri, and I. Vitale Cell death modalities: classification and pathophysiological implications Cell Death Differ 14 2007 1237 1243
18. G. Kroemer, L. Galluzzi, and P. Vandenabeele Nomenclature Committee on Cell Death 2009. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009 Cell Death Differ 16 2009 3 11
19. L. Galluzzi, I. Vitale, and J.M. Abrams Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012 Cell Death Differ 19 2012 107 120
20. J.F. Kerr, A.H. Wyllie, and A.R. Currie Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br J Cancer 26 1972 239 257
21. L. Galluzzi, J.M. Vicencio, O. Kepp, E. Tasdemir, M.C. Maiuri, and G. Kroemer To die or not to die: that is the autophagic question Curr Mol Med 8 2008 78 91
22. B. Levine, and J. Yuan Autophagy in cell death: an innocent convict? J Clin Invest 115 2005 2679 2688
23. P. Golstein, and G. Kroemer Cell death by necrosis: towards a molecular definition Trends Biochem Sci 32 2007 37 43
24. E.H. Baehrecke How death shapes life during development Nat Rev Mol Cell Biol 3 2002 779 787
25. D.H. Barkla, and P.R. Gibson The fate of epithelial cells in the human large intestine Pathology 31 1999 230 238
26. H.I. Roach, and N.M. Clarke Physiological cell death of chondrocytes in vivo is not confined to apoptosis. New observations on the mammalian growth plate J Bone Joint Surg Br 82 2000 601 613
27. B. Robaye, R. Mosselmans, and W. Fiers Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro Am J Pathol 38 1991 447 453
28. T. Suda, T. Takahashi, P. Golstein, and S. Nagata Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family Cell 75 1993 1169 1178
29. Y. Tsujimoto Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria? Genes Cells 3 1998 697 707
30. E. Lomonosova, and G. Chinnadurai BH3-only proteins in apoptosis and beyond: an overview Oncogene 27 Suppl. 1 2008 S2 S19
31. P. Marchetti, M. Castedo, and S.A. Susin Mitochondrial permeability transition is a central coordinating event of apoptosis J Exp Med 184 1996 1155 1160
32. W. Mughal, R. Dhingra, and L.A. Kirshenbaum Striking a balance: autophagy, apoptosis, and necrosis in a normal and failing heart Curr Hypertens Rep 14 2012 540 547
33. R.J. Collins, B.V. Harmon, G.C. Gobe, and J.F.R. Kerr Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis Int J Radiat Biol 61 1992 451 453
34. C. Charriaut-Marlangue, and Y. Ben-Ari A cautionary note on the use of the TUNEL stain to determine apoptosis Neuroreport 7 1995 61 64
35. M.M. Kockx, J. Muhring, H. Bortier, G.R. De Meyer, and W. Jacob Biotin- or digoxigenin-conjugated nucleotides bind to matrix vesicles in atherosclerotic plaques Am J Pathol 148 1996 1771 1777
36. Z. Dong, P. Saikumar, J.M. Weinberg, and M.A. Venkatachalam Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death. Involvement of serine but not cysteine proteases Am J Pathol 151 1997 1205 1213
37. M.M. Kockx, J. Muhring, M.W. Knaapen, and G.R. de Meyer RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis Am J Pathol 152 1998 885 888
38. L.M. Buja, and M.L. Entman Modes of myocardial cell injury and cell death in ischemic heart disease Circulation 98 1998 1355 1357
39. G.D. Sloop, J.C. Roa, A.G. Delgado, J.T. Balart, M.O. Hines III, and J.M. Hill Histologic sectioning produces TUNEL reactivity. A potential cause of false-positive staining Arch Pathol Lab Med 123 1999 529 532
40. P.M. Kang, and S. Izumo Apoptosis in heart failure: is there light at the end of the tunnel (TUNEL)? J Card Fail 6 2000 43 46
41. H. Sakahira, M. Enari, Y. Ohsawa, Y. Uchiyama, and S. Nagata Apoptotic nuclear morphological change without DNA fragmentation Curr Biol 9 1999 543 546
42. G. Takemura, S. Kato, and T. Aoyama Characterization of ultrastructure and its relation with DNA fragmentation in Fas-induced apoptosis of cultured cardiac myocytes J Pathol 193 2001 546 556
43. F. Sam, D.B. Sawyer, and D.L. Chang Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart Am J Physiol Heart Circ Physiol 279 2000 H422 H428
44. F. Sam, D.B. Sawyer, and Z. Xie Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction Circ Res 89 2001 351 356
45. M. Odashima, S. Usui, and H. Takagi Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction Circ Res 100 2007 1344 1352
46. D.K. Singla, G.E. Lyons, and T.J. Kamp Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling Am J Physiol Heart Circ Physiol 293 2007 H1308 H1314
47. R. Shibata, Y. Izumiya, and K. Sato Adiponectin protects against the development of systolic dysfunction following myocardial infarction J Mol Cell Cardiol 42 2007 1065 1074
48. Y. Li, G. Takemura, and H. Okada ANG II type 1A receptor signaling causes unfavorable scar dynamics in the postinfarct heart Am J Physiol Heart Circ Physiol 292 2007 H946 H953
49. F.N. Salloum, A. Abbate, and A. Das Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice Am J Physiol Heart Circ Physiol 294 2008 H1398 H1406
50. A. Abbate, F.N. Salloum, and E. Vecile Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction Circulation 117 2008 2670 2683
51. H. Okada, G. Takemura, and K. Kosai Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure Circulation 111 2005 2430 2437
52. L. Li, H. Okada, and G. Takemura Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction Am J Physiol Heart Circ Physiol 297 2009 H1504 H1513
53. N. Li, J.Y. Liu, and V. Timofeyev Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: insight gained using metabolomic approaches J Mol Cell Cardiol 47 2009 835 845
54. Q. Liu, M.A. Sargent, A.J. York, and J.D. Molkentin ASK1 regulates cardiomyocyte death but not hypertrophy in transgenic mice Circ Res 105 2009 1110 1117
55. M. Marketou, E. Kintsurashvili, K.N. Papanicolaou, H.A. Lucero, I. Gavras, and H. Gavras Cardioprotective effects of a selective B(2) receptor agonist of bradykinin post-acute myocardial infarct Am J Hypertens 23 2010 562 568
56. Q. Li, S. Turdi, D.P. Thomas, T. Zhou, and J. Ren Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction Toxicol Lett 195 2010 119 126
57. V.V. Didenko, and P.J. Hornsby Presence of double-strand breaks with single-base 3′ overhangs in cells undergoing apoptosis but not necrosis J Cell Biol 135 1996 1369 1376
58. A. Frustaci, C. Chimenti, and M. Setoguchi Cell death in acromegalic cardiomyopathy Circulation 99 1999 1426 1434
59. M. Koda, G. Takemura, and M. Kanoh Myocytes positive for in situ markers for DNA breaks in human hearts which are hypertrophic, but neither failed nor dilated: a manifestation of cardiac hypertrophy rather than failure J Pathol 199 2003 229 236
60. S.E. Hughes Detection of apoptosis using in situ markers for DNA strand breaks in the failing human heart. Fact or epiphenomenon? J Pathol 201 2003 181 186
61. P. Anversa Myocyte death in the pathological heart Circ Res 86 2000 121 124
62. J.E. Chipuk, and D.R. Green Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol 6 2005 268 275
63. C. Garrido, and G. Kroemer Life's smile, death's grin: vital functions of apoptosis-executing proteins Curr Opin Cell Biol 16 2004 639 646
64. L. Galluzzi, N. Joza, and E. Tasdemir No death without life: vital functions of apoptotic effectors Cell Death Differ 15 2008 1113 1123
65. P. Vandenabeele, T. Vanden Berghe, and N. Festjens Caspase inhibitors promote alternative cell death pathways Sci STKE 2006 2006 pe44
66. V. Temkin, Q. Huang, H. Liu, H. Osada, and R.M. Pope Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis Mol Cell Biol 26 2006 2215 2225
67. D. Vercammen, R. Beyaert, and G. Denecker Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor J Exp Med 187 1998 1477 1485
68. P. Golstein, and G. Kroemer Redundant cell death mechanisms as relics and backups Cell Death Differ 12 Suppl. 2 2005 1490 1496
69. S.A. Susin, E. Daugas, and L. Ravagnan Two distinct pathways leading to nuclear apoptosis J Exp Med 192 2000 571 580
70. M.Y. Yang, H. Chuang, R.F. Chen, and K.D. Yang Reversible phosphatidylserine expression on blood granulocytes related to membrane perturbation but not DNA strand breaks J Leukoc Biol 71 2002 231 237
71. J.I. Elliott, A. Surprenant, and F.M. Marelli-Berg Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes Nat Cell Biol 7 2005 808 816
72. P. Waring, D. Lambert, A. Sjaarda, A. Hurne, and J. Beaver Increased cell surface exposure of phosphatidylserine on propidium iodide negative thymocytes undergoing death by necrosis Cell Death Differ 6 1999 624 637
73. O. Krysko, L. De Ridder, and M. Cornelissen Phosphatidylserine exposure during early primary necrosis (oncosis) in JB6 cells as evidenced by immunogold labeling technique Apoptosis 9 2004 495 500
74. E.A. Dumont, L. Hofstra, and W.L. van Heerde Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model Circulation 102 13 2000 1564 1568
75. N. Zamzami, and G. Kroemer The mitochondrion in apoptosis: how Pandora's box opens Nat Rev Mol Cell Biol 2 2001 67 71
76. M. Crompton On the involvement of mitochondrial intermembrane junctional complexes in apoptosis Curr Med Chem 10 2003 1473 1484
77. D.R. Green, and G. Kroemer The pathophysiology of mitochondrial cell death Science 305 2004 626 629
78. T. Nakagawa, S. Shimizu, and T. Watanabe Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death Nature 434 2005 652 658
79. C.P. Baines, R.A. Kaiser, and N.H. Purcell Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death Nature 434 2005 658 662
80. Y. Tsujimoto, and S. Shimizu Role of the mitochondrial membrane permeability transition in cell death Apoptosis 12 2007 835 840
81. S. Shimizu, Y. Eguchi, and W. Kamiike Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux Proc Natl Acad Sci U S A 95 1998 1455 1459
82. I. Marzo, C. Brenner, and N. Zamzami The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2-related proteins J Exp Med 187 1998 1261 1271
83. B. Levine, and D.J. Klionsky Development by self-digestion: molecular mechanisms and biological functions of autophagy Dev Cell 6 2004 463 477
84. T. Shintani, and D.J. Klionsky Autophagy in health and disease: a double-edged sword Science 306 2004 990 995
85. J.J. Lum, R.J. DeBerardinis, and C.B. Thompson Autophagy in metazoans: cell survival in the land of plenty Nat Rev Mol Cell Biol 6 2005 439 448
86. D.J. Klionsky, F.C. Abdalla, and H. Abeliovich Guidelines for the use and interpretation of assays for monitoring autophagy Autophagy 8 2012 445 544
87. X. Zeng, J.H. Overmeyer, and W.A. Maltese Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking J Cell Sci 19 2006 259 270
88. S. Pattingre, A. Tassa, and X. Qu Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy Cell 122 2005 927 939
89. E. Zalckvar, H. Berissi, and L. Mizrachy DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy EMBO Rep 10 2009 285 292
90. A. Criollo, M. Niso-Santano, and S.A. Malik Inhibition of autophagy by TAB2 and TAB3 EMBO J 30 2011 4908 4920
91. Y. Zhu, L. Zhao, and L. Liu Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis Protein Cell 1 2010 468 477
92. P.G. Clarke Developmental cell death: morphological diversity and multiple mechanisms Anat Embryol 181 1990 195 213
93. L. Yu, A. Alva, and H. Su Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8 Science 304 2004 1500 1502
94. S. Shimizu, T. Kanaseki, and N. Mizushima Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes Nat Cell Biol 6 2004 1221 1228
95. E.H. Baehrecke Autophagy: dual roles in life and death? Nat Rev Mol Cell Biol 6 2005 505 510
96. P. Boya, R.A. González-Polo, and N. Casares Inhibition of macroautophagy triggers apoptosis Mol Cell Biol 25 2005 1025 1040
97. R. Maruyama, K. Goto, and G. Takemura Morphological and biochemical characterization of basal and starvation-induced autophagy in isolated adult rat cardiomyocytes Am J Physiol Heart Circ Physiol 295 2008 H1599 H1607
98. G. Takemura, R. Maruyama, and K. Goto Fate of isolated adult cardiomyocytes undergoing starvation-induced autophagic degeneration Autophagy 5 2009 90 92
99. A. Hamacher-Brady, N.R. Brady, and R.A. Gottlieb Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes J Biol Chem 281 2006 29776 29787
100. L. Yan, D.E. Vatner, and S.J. Kim Autophagy in chronically ischemic myocardium Proc Natl Acad Sci U S A 102 2005 13807 13812
101. Y. Matsui, H. Takagi, and X. Qu Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy Circ Res 100 2007 914 922
102. A. Nakai, O. Yamaguchi, and T. Takeda The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress Nat Med 13 2007 619 624
103. H. Kanamori, G. Takemura, and R. Maruyama Functional significance and morphological characterization of starvation-induced autophagy in the adult heart Am J Pathol 174 2009 1705 1714
104. H. Kanamori, G. Takemura, and K. Goto The role of autophagy emerging in postinfarction cardiac remodelling Cardiovasc Res 91 2011 330 339
105. H. Kanamori, G. Takemura, and K. Goto Autophagy limits acute myocardial infarction induced by permanent coronary artery occlusion Am J Physiol Heart Circ Physiol 300 2011 H2261 H2271
106. G. Majno, and I. Joris Apoptosis, oncosis, and necrosis. An overview of cell death Am J Pathol 146 1995 3 15
107. G. Denecker, D. Vercammen, W. Declercq, and P. Vandenabeele Apoptotic and necrotic cell death induced by death domain receptors Cell Mol Life Sci 58 2001 356 370
108. P. Nicotera, and G. Melino Regulation of the apoptosis-necrosis switch Oncogene 23 2004 2757 2765
109. R.B. Jennings, and K.A. Reimer Lethal myocardial ischemic injury Am J Pathol 102 1981 241 255
110. J.L. Farber Biology of disease: membrane injury and calcium homeostasis in the pathogenesis of coagulative necrosis Lab Invest 47 1982 114 123
111. M. Henriquez, R. Armisén, A. Stutzin, and A.F. Quest Cell death by necrosis, a regulated way to go Curr Mol Med 8 2008 187 206
112. P. Nicotera, F. Bernassola, and G. Melino Nitric oxide (NO), a signaling molecule with a killer soul Cell Death Differ 6 1999 931 933
113. N. Festjens, T. Vanden Berghe, S. Cornelis, and P. Vandenabeele RIP1, a kinase on the crossroads of a cell's decision to live or die Cell Death Differ 14 2007 400 410
114. W.R. MacLellan, and M.D. Schneider Death by design. Programmed cell death in cardiovascular biology and disease Circ Res 81 1997 137 144
115. M.J. Davies Apoptosis in cardiovascular disease Heart 77 1997 498 501
116. H. Yaoita, K. Ogawa, K. Maehara, and Y. Maruyama Apoptosis in relevant clinical situations: contribution of apoptosis in myocardial infarction Cardiovasc Res 45 2000 630 641
117. M. Rodriguez, B.R. Lucchesi, and J. Schaper Apoptosis in myocardial infarction Ann Med 34 2002 470 479
118. J.L. Reeve, A.M. Duffy, T. O'Brien, and A. Samali Don't lose heart - therapeutic value of apoptosis prevention in the treatment of cardiovascular disease J Cell Mol Med 9 2005 609 622
119. C. Masri, and Y. Chandrashekhar Apoptosis: a potentially reversible, meta-stable state of the heart Heart Fail Rev 13 2008 175 179
120. A. Baldi, A. Abbate, and R. Bussani Apoptosis and post-infarction left ventricular remodeling J Mol Cell Cardiol 34 2002 165 174
121. A. Abbate, R. Bussani, and G.G. Biondi-Zoccai Persistent infarct-related artery occlusion is associated with an increased myocardial apoptosis at postmortem examination in humans late after an acute myocardial infarction Circulation 106 2002 1051 1054
122. W. Cheng, J. Kajstura, and J.A. Nitahara Programmed myocyte cell death affects the viable myocardium after infarction in rats Exp Cell Res 226 1996 316 327
123. V.G. Sharov, H.N. Sabbah, H. Shimoyama, A.V. Goussev, M. Lesch, and S. Goldstein Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure Am J Pathol 148 1996 141 149
124. L. Jiang, Y. Huang, T. Yuasa, S. Hunyor, and C.G. dos Remedios Elevated DNase activity and caspase expression in association with apoptosis in failing ischemic sheep left ventricles Electrophoresis 20 1999 2046 2052
125. G.D. Dispersyn, L. Mesotten, and B. Meuris Dissociation of cardiomyocyte apoptosis and dedifferentiation in infarct border zones Eur Heart J 23 2002 849 857
126. C. Chen, L. Ma, and D.R. Linfert Myocardial cell death and apoptosis in hibernating myocardium J Am Coll Cardiol 30 1997 1407 1412
127. D. Wencker, M. Chandra, and K. Nguyen A mechanistic role for cardiac myocyte apoptosis in heart failure J Clin Invest 111 2003 1497 1504
128. G. Condorelli, R. Roncarati, and J. Ross Jr. Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function Proc Natl Acad Sci U S A 98 2001 9977 9982
129. D.P. Nelson, E. Setser, and D.G. Hall Proinflammatory consequences of transgenic Fas ligand expression in the heart J Clin Invest 105 2000 1199 1208
130. T. Kubota, M. Miyagishima, and C.S. Frye Overexpression of tumor necrosis factor- alpha activates both anti- and pro-apoptotic pathways in the myocardium J Mol Cell Cardiol 33 2001 1331 1344
131. I. Falcão-Pires, and A.F. Leite-Moreira Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment Heart Fail Rev 17 2012 325 344
132. T. Koseki, N. Inohara, S. Chen, and G. Nunez ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases Proc Natl Acad Sci U S A 95 1998 5156 5160
133. S.M. Srinivasula, M. Ahmad, and S. Ottilie FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas/TNFR1-induced apoptosis J Biol Chem 272 1997 18542 18545
134. A.M. Chinnaiyan, K. O'Rourke, M. Tewari, and V.M. Dixit FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis Cell 81 1995 505 512
135. Q.L. Deveraux, R. Takahashi, G.S. Salvesen, and J.C. Reed X-linked IAP is a direct inhibitor of cell-death proteases Nature 388 1997 300 304
136. S. Gupta, and A.A. Knowlton HSP60, Bax, apoptosis and the heart J Cell Mol Med 9 2005 51 58
137. V.P. van Empel, A.T. Bertrand, L. Hofstra, H.J. Crijns, P.A. Doevendans, and L.J. De Windt Myocyte apoptosis in heart failure Cardiovasc Res 67 2005 21 29
138. H. Yaoita, K. Ogawa, K. Maehara, and Y. Maruyama Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor Circulation 97 1998 276 281
139. T.A. Holly, A. Drincic, and Y. Byun Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo J Mol Cell Cardiol 31 1999 1709 1715
140. M.M. Mocanu, G.F. Baxter, and D.M. Yellon Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury Br J Pharmacol 130 2000 197 200
141. P. Kovacs, I. Bak, and L. Szendrei Non-specific caspase inhibition reduces infarct size and improves post-ischaemic recovery in isolated ischaemic/reperfused rat hearts Naunyn Schmiedebergs Arch Pharmacol 364 2001 501 507
142. Z.Q. Zhao, C.D. Morris, and J.M. Budde Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion Cardiovasc Res 59 2003 132 142
143. T. Okamura, T. Miura, and G. Takemura Effect of caspase inhibitors on myocardial infarct size and myocyte DNA fragmentation in the ischemia-reperfused rat heart Cardiovasc Res 45 2000 642 650
144. S. Minatoguchi, T. Kariya, and Y. Uno Caspase-dependent and serine protease-dependent DNA fragmentation of myocytes in the ischemia-reperfused rabbit heart: these inhibitors do not reduce infarct size Jpn Circ J 65 2001 907 911
145. H. Ruetten, C. Badorff, C. Ihling, A.M. Zeiher, and S. Dimmeler Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects J Am Coll Cardiol 38 2001 2063 2070
146. C. Perrin, A. Ecarnot-Laubriet, C. Vergely, and L. Rochette Calpain and caspase-3 inhibitors reduce infarct size and post-ischemic apoptosis in rat heart without modifying contractile recovery Cell Mol Biol (Noisy-le-Grand) 49 2003 OL497 OL505
147. The CONSENSUS Trial Study Group Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group N Engl J Med 316 1987 1429 1435
148. The SOLVD Investigators Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators N Engl J Med 325 1991 293 302
149. M. Packer, M.R. Bristow, and J.N. Cohn The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group N Engl J Med 334 1996 1349 1355
150. CIBIS II Investigators The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
151. M.I. Oerlemans, S. Koudstaal, S.A. Chamuleau, D.P. de Kleijn, P.A. Doevendans, and J.P. Sluijter Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection Int J Cardiol 165 3 2013 410 422
152. E.S. Chung, M. Packer, K.H. Lo, A.A. Fasanmade, and J.T. Willerson Anti-TNF Therapy Against Congestive Heart Failure Investigators. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial Circulation 107 2003 3133 3140
153. D.L. Mann, J.J. McMurray, and M. Packer Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) Circulation 109 2004 1594 1602
154. R.B. Jennings, J.H. Baum, and P.B. Herdson Fine structural changes in myocardial ischemic injury Arch Pathol 79 1965 135 143
155. R.A. Kloner, C.E. Ganote, D.A. Whalen Jr., and R.B. Jennings Effect of a transient period of ischemia on myocardial cells. II. Fine structure during the first few minutes of reflow Am J Pathol 74 1974 399 422
156. S. Hein, E. Arnon, and S. Kostin Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms Circulation 107 2003 984 991
157. Z. Zhang, R. Vezza, and T. Plappert COX-2-dependent cardiac failure in Gh/tTG transgenic mice Circ Res 92 2003 1153 1561
158. M. Sano, S.C. Wang, and M. Shirai Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure EMBO J 23 2004 3559 3569
159. D. Engel, R. Peshock, R.C. Armstong, N. Sivasubramanian, and D.L. Mann Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression Am J Physiol Heart Circ Physiol 287 2004 H1303 H1311
160. R. Ricci, U. Eriksson, and G.Y. Oudit Distinct functions of junD in cardiac hypertrophy and heart failure Genes Dev 19 2005 208 213
161. H. Toko, T. Oka, and Y. Zou Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy Hypertens Res 25 2002 597 603
162. S.A. Crone, Y.Y. Zhao, and L. Fan ErbB2 is essential in the prevention of dilated cardiomyopathy Nat Med 8 2002 459 465
163. T.F. Chu, M.A. Rupnick, and R. Kerkela Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib Lancet 370 2007 2011 2019
164. A.B. Borisov, A.V. Ushakov, and A.K. Zagorulko Intracardiac lipid accumulation, lipoatrophy of muscle cells and expansion of myocardial infarction in type 2 diabetic patients Micron 39 2008 944 951
165. S. Kostin, L. Pool, and A. Elsasser Myocytes die by multiple mechanisms in failing human hearts Circ Res 92 2003 715 724
166. J.J. Liu, L. Peng, C.J. Bradley, A. Zulli, J. Shen, and B.F. Buxton Increased apoptosis in the heart of genetic hypertension, associated with increased fibroblasts Cardiovasc Res 45 2000 729 735
167. G. Condorelli, C. Morisco, and G. Stassi Increased cardiomyocyte apoptosis and changes in proapoptotic and antiapoptotic genes Bax and Bcl-2 during left ventricular adaptations to chronic pressure overload in the rat Circulation 99 1999 3071 3078
168. T. Walther, C. Tschöpe, and A. Sterner-Kock Accelerated mitochondrial adenosine diphosphate/adenosine triphosphate transport improves hypertension-induced heart disease Circulation 115 2007 333 344
169. Y. Hayakawa, M. Chandra, and W. Miao Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of Galpha(q) transgenic mice Circulation 108 2003 3036 3041
170. B. Levkau, M. Schäfers, and J. Wohlschlaeger Survivin determines cardiac function by controlling total cardiomyocyte number Circulation 117 2008 1583 1593
171. U. Baandrup, R.A. Florio, F. Roters, and E.G. Olsen Electron microscopic investigation of endomyocardial biopsy samples in hypertrophy and cardiomyopathy. A semiquantitative study in 48 patients Circulation 63 1981 1289 1298
172. M. Koda, G. Takemura, and H. Okada Nuclear hypertrophy reflects increased biosynthetic activities in myocytes of human hypertrophic hearts Circ J 70 2006 710 718
173. S. Guerra, A. Leri, and X. Wang Myocyte death in the failing human heart is gender dependent Circ Res 85 1999 856 866
174. J. Schaper, A. Elsässer, and S. Kostin The role of cell death in heart failure Circ Res 85 1999 867 869
175. A. Abbate, M. De Falco, and C. Morales Electron microscopy characterization of cardiomyocyte apoptosis in ischemic heart disease Int J Cardiol 114 2007 118 120
176. M. Prech, A. Marszałek, and J. Schröder Apoptosis as a mechanism for the elimination of cardiomyocytes after acute myocardial infarction Am J Cardiol 105 2010 1240 1245
177. R. Maruyama, G. Takemura, and T. Aoyama Dynamic process of apoptosis in adult rat cardiomyocytes analyzed using 48-hour videomicroscopy and electron microscopy: beating and rate are associated with the apoptotic process Am J Pathol 159 2001 683 691
178. S. Kato, G. Takemura, and R. Maruyama Apoptosis, rather than oncosis, is the predominant mode of spontaneous death of isolated adult rat cardiac myocytes in culture Jpn Circ J 65 2001 743 748
179. K. Hayakawa, G. Takemura, and M. Koda Sensitivity to apoptosis signal, clearance rate, and ultrastructure of Fas ligand-induced apoptosis in in vivo adult cardiac cells Circulation 105 2002 3039 3045
180. R. Maruyama, G. Takemura, and N. Tohse Synchronous progression of calcium transient-dependent beating and sarcomere destruction in apoptotic adult cardiomyocytes Am J Physiol Heart Circ Physiol 290 2006 H1493 H1502
181. R.B. Jennings, and C.E. Ganote Mitochondrial structure and function in acute myocardial ischemic injury Circ Res 38 Suppl. I 1976 I-80 I-91
182. A.B. Gustafsson, J.G. Tsai, S.E. Logue, M.T. Crow, and R.A. Gottlieb Apoptosis repressor with caspase recruitment domain protects against cell death by interfering with Bax activation J Biol Chem 279 2004 21233 22128
183. S. Donath, P. Li, and C. Willenbockel German Heart Failure Network. Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress Circulation 113 2006 1203 1212
184. T. Imanishi, C.E. Murry, and H. Reinecke Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues Cardiovasc Res 48 2000 101 110
185. S.M. Davidson, A. Stephanou, and D.S. Latchman FLIP protects cardiomyocytes from apoptosis induced by simulated ischemia/reoxygenation, as demonstrated by short hairpin-induced (shRNA) silencing of FLIP mRNA J Mol Cell Cardiol 35 2003 1359 1364
186. A.H. Wyllie Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation Nature 284 1980 555 556
187. N. Nozaki, T. Shishido, Y. Takeishi, and I. Kubota Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice Circulation 110 2004 2869 2874
188. H. Okada, G. Takemura, and M. Koda Myocardial apoptotic index based on in situ DNA nick end-labeling of endomyocardial biopsies does not predict prognosis of dilated cardiomyopathy Chest 128 2005 1060 1062
189. M. Kanoh, G. Takemura, and J. Misao Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair Circulation 99 1999 2757 2764
190. M.W. Knaapen, M.J. Davies, M. De Bie, A.J. Haven, W. Martinet, and M.M. Kockx Apoptotic versus autophagic cell death in heart failure Cardiovasc Res 51 2001 304 312
191. A.C. Nag Study of non-muscle cells of the adult mammalian heart: a fine
192. K.T. Weber, P. Anversa, and P.W. Armstrong Remodeling and reparation of the cardiovascular system J Am Coll Cardiol 20 1992 3 16
193. A. Desmoulière, M. Redard, I. Darby, and G. Gabbiani Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar Am J Pathol 146 1995 56 66
194. G. Takemura, M. Ohno, and Y. Hayakawa Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction Circ Res 82 1998 1130 1138
195. M. Park, Y.T. Shen, and V. Gaussin Apoptosis predominates in nonmyocytes in heart failure Am J Physiol Heart Circ Physiol 297 2009 H785 H791
196. M.H. Soonpaa, and L.J. Field Survey of studies examining mammalian cardiomyocyte DNA synthesis Circ Res 83 1998 15 26
197. J. Narula, P. Pandey, and E. Arbustini Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy Proc Natl Acad Sci U S A 96 1999 8144 8149
198. 2 +- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure J Clin Invest 117 2007 2431 2444
199. B.E. McKenzie, B.C. Easterday, and J.A. Will Light and electron microscopic changes in the myocardium of influenza-infected turkeys Am J Pathol 69 1972 239 254
200. Y. Sato, T. Kita, Y. Takatsu, and T. Kimura Biochemical markers of myocyte injury in heart failure Heart 90 2004 1110 1113
201. A.W. Leung, and A.P. Halestrap Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore Biochim Biophys Acta 1777 2008 946 952
202. G. Mallory, P. White, and J. Salcedo-Salga The speed of healing of myocardial infarction: a study of the pathologic anatomy in 72 cases Am Heart J 18 1939 647 671
203. M.C. Fishbein, D. Maclean, and P.R. Maroko Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution Am J Pathol 90 1978 57 70
204. L.C. Katwa, S.E. Campbell, S.C. Tyagi, S.J. Lee, G.T. Cicila, and K.T. Weber Cultured myofibroblasts generate angiotensin peptides de novo J Mol Cell Cardiol 29 1997 1375 1386
205. K. Hayakawa, G. Takemura, and M. Kanoh Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage Circulation 108 2003 104 109
206. Y. Li, G. Takemura, and K. Kosai Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure Circ Res 95 2004 627 636
207. H. Kanamori, G. Takemura, and Y. Li Inhibition of Fas-associated apoptosis in granulation tissue cells accompanies attenuation of postinfarction left ventricular remodeling by olmesartan Am J Physiol Heart Circ Physiol 292 2007 H2184 H2194
208. A. Ogino, G. Takemura, and H. Kanamori Amlodipine inhibits granulation tissue cell apoptosis through reducing calcineurin activity to attenuate postinfarction cardiac remodeling Am J Physiol Heart Circ Physiol 293 2007 H2271 H2280
209. M. Nakagawa, G. Takemura, and H. Kanamori Mechanisms by which late coronary reperfusion mitigates postinfarction cardiac remodeling Circ Res 103 2008 98 106
210. R. von Harsdorf "Fas-ten" your seat belt: anti-apoptotic treatment in heart failure takes off Circ Res 95 2004 554 556